PlainRecalls
FDA Devices Moderate Class II Ongoing

HeartWare Ventricular Assist System (HVAD) For use as a bridge-to-cardiac transplantation in patient who are at risk of death from refractory end-stage left ventricular heart failure.

Reported: June 17, 2015 Initiated: April 29, 2015 #Z-1751-2015

Product Description

HeartWare Ventricular Assist System (HVAD) For use as a bridge-to-cardiac transplantation in patient who are at risk of death from refractory end-stage left ventricular heart failure.

Reason for Recall

Complaints with the HVAD Discolored and Cracked Driveline Outer Sheath.

Details

Recalling Firm
HeartWare Inc
Units Affected
3,747 currently in use
Distribution
AL, AZ, CA, CO, CT, DC, DE, FL, GA, IA, IL, IN, KY, LA, MA, MD, MI, MN, MO, MS, NC, NH, NJ, NY, OH, OR, PA, SC, TN, TX, UT, and VA, Foreign: Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Croatia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Israel, Italy, Japan, Korea, Lebanon, Lithuania, Luxemburg, Malaysia, Netherlands, New Zealand, Norway, Poland, Romania, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, Turkey, and UK,
Location
Miami Lakes, FL

Frequently Asked Questions

What product was recalled?
HeartWare Ventricular Assist System (HVAD) For use as a bridge-to-cardiac transplantation in patient who are at risk of death from refractory end-stage left ventricular heart failure.. Recalled by HeartWare Inc. Units affected: 3,747 currently in use.
Why was this product recalled?
Complaints with the HVAD Discolored and Cracked Driveline Outer Sheath.
Which agency issued this recall?
This recall was issued by the FDA Devices on June 17, 2015. Severity: Moderate. Recall number: Z-1751-2015.